News
West Pharmaceutical Services shares have dropped 35% in 2025, despite better-than-expected Q1 results, with forward guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback